Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesEffectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Tanzilli G et al. – A 2–year dual antiplatelet regimen with aspirin and clopidogrel can prevent the occurrence of very late stent thrombosis after PCI with DESs.
Related Articles
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
Circulation, 11/04/09
Relevance Score: 68%
Intravascular Ultrasound Assessment of the Incidence and Predictors of Edge Dissections After Drug-Eluting Stent Implantation
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/23/09
Relevance Score: 68%
Clinical Outcomes After Sirolimus-Eluting, Paclitaxel-Eluting, and Bare Metal Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)
The American Journal of Cardiology, 11/09/09
Relevance Score: 67%
Degradable and drug-eluting stents: Mixed results
Urology Times, 11/04/09
Relevance Score: 67%
Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months
Vascular Medicine, 10/15/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis
Journal of Rheumatology, 11/20/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Oxidative Stress and Platelet Activation: Markers of Myocardial Infarction in Type 2 Diabetes Mellitus
Angiology, 11/20/09
Mechanisms of Tissue Injury in Renal Artery Stenosis: Ischemia and Beyond
Progress in Cardiovascular Diseases , 11/20/09
Feasibility and Safety of Transcatheter Intervention for Complex Patent Ductus Arteriosus
Angiology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor